Brookstone Capital Management Ampio Pharmaceuticals, Inc. Transaction History

Brookstone Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 13, 2022	SELL	$0.08 - $21.0 $200 - $52,500	-2,500 Reduced 11.81%	18,675 $1,000
Q1 2021 Apr 16, 2021	BUY	$1.36 - $2.49 $9,520 - $17,430	7,000 Added 49.38%	21,175 $36,000
Q4 2020 Jan 13, 2021	BUY	$0.75 - $2.76 $1,781 - $6,554	2,375 Added 20.13%	14,175 $23,000
Q2 2018 Aug 06, 2018	BUY	$1.66 - $3.82 $19,588 - $45,076	11,800 New	11,800 $26,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

Stay updated on Brookstone Capital Management with notifications on news.